ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Is the NETos Increased in Acute Antibody Mediated Rejection?

    R. Villca-Gonzales,1 J. Torres-Ruiz,2 D. Gomez-Martin,2 J. Alberu,3 L. Morales-Buenrostro.1

    1Nephrology, Inst. Nacional de Ciencias Médicas y Nutrición SZ, Mexico City, CDMX, Mexico; 2Immunology, Inst. Nacional de Ciencias Médicas y Nutrición SZ, Mexico City, CDMX, Mexico; 3Transplantation, Inst. Nacional de Ciencias Médicas y Nutrición SZ, Mexico City, CDMX, Mexico.

    Neutrophils can promote graft inflammation through a form of programmed cell death termed "NETosis". How alloantibodies contribute to neutrophil responses in grafts is not clear…
  • 2018 American Transplant Congress

    Haematological Autoimmune Disorders Associated with Alemtuzumab Induction in Renal and Simultaneous Pancreas and Kidney Recipients

    A. Kousios,1 R. Charif,1 M. Atta,2 A. Luqmani,2 N. Cooper,2 D. Taube.1

    1Renal and Transplant Centre, Imperial College NHS Trust, London, United Kingdom; 2Department of Haematology, Imperial College NHS Trust, London, United Kingdom.

    Introduction Haematological Autoimmune Disorders (HAD) have been associated with Alemtuzumab (Az); namely immune thrombocytopenia (ITP), autoimmune haemolytic anaemia (AIHA), Evans syndrome (ES) and Red Cell…
  • 2018 American Transplant Congress

    Transplant Candidates and Potential Living Kidney Donors Are Supportive of Reciprocity for Transplant Candidates Who Participate in Kidney Paired Donation with a Compatible Donor

    J. Gill,1 J. Gill,1 F. Ballesteros,2 M. Fortin.2

    1UBC, Vancouver, Canada; 2Centre de Recherche du CHUM, Montreal, Canada.

    The inclusion of compatible pairs in kidney paired donation (KPD) is a strategy to increase transplantation for incompatible pairs in KPD. We proposed a reciprocity…
  • 2018 American Transplant Congress

    Outpatient Prophylactic Valganciclovir Dose Optimization Post-Renal Transplant

    M. Spinner,1 V. Athans,1 C. Koval.2

    1Dept. of Pharmacy, Cleveland Clinic, Cleveland, OH; 2Dept. of Infectious Diseases, Cleveland Clinic, Cleveland, OH.

    Purpose: Renal function rapidly changes post-transplant requiring dose adjustment of CMV prophylaxis. We describe valganciclovir (VGCV) dosing accuracy in the outpatient setting and its associated…
  • 2018 American Transplant Congress

    Prevention of Hepatitis B Virus Reactivation in HBsAg-Positive Renal Transplant Recipients with Rituximab Treatment

    J. Choi, J. Jung, H. Kwon, S. Shin, Y. Kim, D. Han.

    Division of Kidney and Pancreas Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

    Background: The risk of Hepatitis B virus (HBV) reactivation under immunosuppressant has been well known. Hepatitis B virus reactivation increase patient mortality and graft failure…
  • 2018 American Transplant Congress

    The Impact of Immunosuppression on Mineral Metabolism One Year after Kidney Transplantation: Differences between a Mycophenolate-Based Regimen versus an mTOR-Inhibitor-Based One

    D. Cucchiari,1 S. Karam,2 P. Ventura-Aguiar,1 F. Diekmann,1 J. Torregrosa.1

    1Renal Transplant Unit, Hospital Clinic, Barcelona, Spain; 2Department of Medicine, Saint George Hospital University Medical Center, Beirut, Lebanon.

    INTRODUCTION: after kidney transplantation, a substantial amount of patients still suffer from Mineral Bone Disorder. The role of different immunosuppressive therapies on mineral metabolism in…
  • 2018 American Transplant Congress

    Influence of mTOR Inhibitors on Metabolic Outcomes One Year after Kidney Transplantation: The Role of Pre-Transplantation Diabetes

    D. Cucchiari,1 S. Karam,2 P. Ventura-Aguiar,1 J. Torregrosa,1 F. Diekmann.1

    1Renal Transplant Unit, Hospital Clínic, Barcelona, Spain; 2Department of Medicine, Saint George Hospital, Beirut, Lebanon.

    INTRODUCTION: mTOR inhibitors alter lipids and carbohydrate metabolism in kidney transplant recipients. Little is known if there is any difference between patients who were already…
  • 2018 American Transplant Congress

    Lactate/platelet Ratio after Liver Transplantation; a Novel Predictor for Short-Term Graft Failure

    K. Takahashi,1 S. Nagai,2 M. Safwan,2 K. Collins,2 M. Rizzari,2 A. Yoshida,2 N. Ohkohchi,1 M. Abouljoud.2

    1Surgery, University of Tsukuba, Tsukuba, Ibaraki, Japan; 2Transplant, Henry Ford Hospital, Detroit, MI.

    Background; Recently, platelet count and lactate level after liver transplantation (LT) have been both separately reported as predictors of graft failure. In this study, we…
  • 2018 American Transplant Congress

    Transplant Hepatectomy with Portacaval Shunt and Molecular Adsorbent Recirculating System (MARS) Therapy for Perioperative Catastrophe

    A. Cimeno, S. Sultan, J. Alvarez-Casas, S. Hanish, D. Bruno, W. Hutson, D. Stein, T. Scalea, R. Barth, J. LaMattina.

    University of Maryland School of Medicine, Baltimore, MD.

    Background: Increased worldwide focus on maximal donor utilization and transplantation of patients once considered too ill to survive liver transplantation may increase the otherwise rare…
  • 2018 American Transplant Congress

    The Neutrophil to Lymphocyte Ratio is Confounded by MELD in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation

    J. McVey, K. Sasaki, F. Dan, Q. Cristiano, H. Koji, M. Charles, A. Federico.

    Department of General Surgery Digestive Disease Institute, Cleveland Clinic, Cleveland, OH.

    Background: Biological markers such as the pre-operative neutrophil to lymphocyte ratio (NLR) have been suggested to be valuable indicators of recurrence and overall survival after…
  • « Previous Page
  • 1
  • …
  • 114
  • 115
  • 116
  • 117
  • 118
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences